Wells Fargo & Company MN boosted its stake in Dynavax Technologies Corp. by 4.1% during the third quarter, according to its most recent 13F filing with the SEC. The fund owned 14,433 shares of the biopharmaceutical company’s stock after buying an additional 563 shares during the period.